-+ 0.00%
-+ 0.00%
-+ 0.00%

Stoke Therapeutics grants inducement stock options for 53,175 shares at USD 28.15 each

PUBT·09/16/2026 20:01:39
Listen to the news
Stoke Therapeutics grants inducement stock options for 53,175 shares at USD 28.15 each
  • Stoke Therapeutics granted stock options covering 53,175 shares to nine new employees, effective Sept. 15, 2026.
  • Exercise price set at $28.15 per share, matching the stock’s closing price on Sept. 15, 2026.
  • Awards vest over four years: 25% after one year, then monthly over the next 36 months.
  • Options run for 10 years, issued under the 2023 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609161601BIZWIRE_USPR_____20260916_BW418456) on September 16, 2026, and is solely responsible for the information contained therein.